Embody, Inc.
- UEI
- TDARNMFL46M1
- CAGE
- 786V6
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- embody-inc.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Asante Bio LLC | Norfolk, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Collamedix Inc. | Shaker Heights, OH | 339113 Surgical Appliance and Supplies Manufacturing |
| Theradaptive Inc. | Frederick, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Ortholevo, Inc. | Lynnfield, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Epibone, Inc. | New York, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Embody, Inc., doing business as Embody, is a commercial stage company specializing in collagen-based tendon and ligament healing products for the sports medicine market. Through its medical device products that leverage regenerative technologies and advanced manufacturing, Embody supports improved care and operational readiness.
Embody has received prime federal contract awards from the Department of Defense, including research and development contracts from the Department of the Air Force Materiel Command Research Laboratory and the Defense Advanced Research Projects Agency. These contracts, set aside for small businesses, funded Embody's efforts to develop innovative biomaterials and biomanufacturing processes for tissue engineering and regenerative medicine applications. Specific areas of research have included three-dimensional bioprinted tissue analogs to address volumetric muscle loss injuries, collagen constructs to accelerate healing of skeletal muscle trauma, and arthroscopically delivered collagen microfiber biotextiles for joint repair. Additionally, Embody was awarded a COVID-19 contract by the Air Force in 2020 to advance its collagen biomaterials production capabilities.
Through a prime federal grant from the Department of Health and Human Services National Institutes of Health, Embody conducted preclinical evaluations on a biofabricated implant for rotator cuff repair. The company also received a prime federal grant from the Department of the Army Medical Command in 2019 to develop high-strength telocollogen fibers for tendon and muscle-tendon regeneration.
Quick answers
Is Embody, Inc. registered in SAM.gov?
Embody, Inc.'s SAM.gov registration expired on March 24, 2025.
What is Embody, Inc.'s most recent federal award?
Embody, Inc.'s most recent federal contract award is Improving care and operational readiness with 3D bioprinted tissue analogs for volumetric muscle loss (FA864922P1044), from Air Force Research Laboratory (AFMC), on July 25, 2022.
On GovTribe
See Embody, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors